Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma

Neuro-Oncology

Volumn 15, Issue 3, 2013, Pages 352-359

  Sung, Ki Woong ^a   Lim, Do Hoon ^a   Son, Meong Hi ^a   Lee, Soo Hyun ^a   Yoo, Keon Hee ^a   Koo, Hong Hoe ^a   Kim, Ji Hye ^a   Suh, Yeon Lim ^a   Joung, Yoo Sook ^a   Shin, Hyung Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

autologous stem cell transplantation; high dose chemotherapy; late effect; medulloblastoma; radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; THIOTEPA; VINCRISTINE;

ADRENAL INSUFFICIENCY; ANDROGEN DEFICIENCY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CATARACT; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CHILDHOOD CANCER; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CRANIOSPINAL IRRADIATION; DRUG MEGADOSE; DRUG SAFETY; ESTROGEN DEFICIENCY; EVENT FREE SURVIVAL; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GLOMERULOPATHY; GROWTH HORMONE DEFICIENCY; HEARING IMPAIRMENT; HIGH RISK PATIENT; HISTOPATHOLOGY; HORMONE DEFICIENCY; HUMAN; HUMAN TISSUE; HYPERKALEMIA; HYPERNATREMIA; HYPERTRANSAMINASEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTHYROIDISM; INDUCTION CHEMOTHERAPY; KIDNEY FAILURE; KIDNEY TUBULE DISORDER; LIVER VEIN OBSTRUCTION; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; MYOCARDITIS; OVERALL SURVIVAL; PRESCHOOL CHILD; PROSPECTIVE STUDY; RADIATION DOSE REDUCTION; RADIATION INJURY; SECOND CANCER; STOMATITIS; THERAPY EFFECT; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MEDULLOBLASTOMA; MELPHALAN; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RISK FACTORS; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THIOTEPA; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84874511870     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos304     Document Type: Article

References (30)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109. (Pubitemid 47103521)
2. Packer RJ, Rood BR, MacDonald TJ. Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg. 2003;39:60-67. (Pubitemid 36829097)
3. Massimino M, Giangaspero F, Garrè ML, et al. Childhood medulloblastoma. Crit Rev Oncol Hematol. 2011;79:65-83.
4. Varan A. Risk-adapted chemotherapy in childhood medulloblastoma. Expert Rev Anticancer Ther. 2011;11:771-780.
5. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17:832-845. (Pubitemid 29109313)
6. Taylor RE, Bailey CC, Robinson KJ, et al. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer. 2005;41:727-734. (Pubitemid 40342556)
7. Kortmann RD, Kü hl J, Timmermann B, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys. 2000;46:269-279. (Pubitemid 30067775)
8. Diller L, Chow EJ, Gurney JG, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27:2339-2355.
9. Gurney JG, Ness KK, Stovall M, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88:4731-4739. (Pubitemid 37357519)
10. Packer RJ, Gurney JG, Punyko JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol. 2003;21:3255-3261. (Pubitemid 46606258)
11. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer. 2003;97:663-673. (Pubitemid 36125844)
12. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:399-408. (Pubitemid 38878043)
13. Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol. 1998;16:1723-1728.
14. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys. 1999;45:137-145. (Pubitemid 29380085)
15. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol. 1999;17:2127-2136. (Pubitemid 29318845)
16. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202-4208. (Pubitemid 46622300)
17. Matthay KK, Reynolds CP, Seeger RC, et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol. 2009;27:1007-1013.
18. Marachelian A, Butturini A, Finlay J. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors. Bone Marrow Transplant. 2008;41: 167-172. (Pubitemid 351188914)
19. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998;16:210-221. (Pubitemid 28041601)
20. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004;22:4881-4887. (Pubitemid 46638611)
21. Fangusaro J, Finlay J, Sposto R, et al. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer. 2008;50: 312-318.
22. Ridola V, Grill J, Doz F, et al. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. Cancer. 2007;110:156-163. (Pubitemid 46986428)
23. Valteau-Couanet D, Fillipini B, Benhamou E, et al. High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. Bone Marrow Transplant. 2005;36: 939-945. (Pubitemid 41741555)
24. Pé rez-Mart?́nez A, Lassaletta A, Gonzá lez-Vicent M, et al. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol. 2005;71:33-38.
25. Aihara Y, Tsuruta T, Kawamata T, et al. Double high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for primary disseminated medulloblastoma: a report of 3 cases. J Pediatr Hematol Oncol. 2010;32:e70-74.
26. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7:813-820. (Pubitemid 44464063)
27. Sung KW, Yoo KH, Cho EJ, et al. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Pediatr Blood Cancer. 2007;48:408-415. (Pubitemid 46340106)
28. Rosenfeld A, Kletzel M, Duerst R, et al. A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors. J Neurooncol. 2010;97: 247-255.
29. Sung KW, Lee SH, Yoo KH, et al. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma. Bone Marrow Transplant. 2007;40:37-45. (Pubitemid 47018412)
30. Northcott PA, Korshunov A, Pfister SM, et al. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol. 2012;8:340-351.